Clinical Research

Kaiser Permanente Commits $63M to Support Contact Tracing in California | PR Newswire | 8/11/2020

… empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research , health education and the support of community health. For more information, contact …

Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for wet AMD, Reports Recent Business Progress and Second Quarter 2020 Financial Results | 8/11/2020

… number of aflibercept IVTs since ADVM-022) / (days from ADVM-022 to the last study follow-up / 365.25) 6 Fluorescein angiography of posterior pole Arshad M. Khanani, M.D., M.A., managing partner and director of clinical research , Sierra Eye Associates, clinical associate professor of ophthalmology, University of Nevada, and top enrolling investigator in the OPTIC trial said, “In my experience the sustained anatomical treatment response following a single intravitreal injection of …

Follow Clinical Research:    

TopAlliance Appoints Patricia Keegan, M.D., as Chief Medical Officer | Globe Newswire | 8/10/2020

… HKEX: 1877; SSE: 688180) today announced the appointment of Dr. Patricia Keegan, as Chief Medical Officer and Senior Vice President. Dr. Keegan brings over three decades of experience as a board-certified medical oncologist, clinical research er, and regulatory authority at FDA. “We are very glad to welcome Patricia on board,” said Ning Li, M.D., Ph.D., Chief Executive Officer of Shanghai Junshi Biosciences. “Dr. Keegan is an accomplished clinician and regulator …

How To Reduce Flatulence & Gas | 8/10/2020

… spices in your diet. 1. Ginger Ginger is known as a potent gastrointestinal medicine that is commonly used in traditional medicine for treating nausea, colic, indigestion, vomiting, gastroenteritis, bloating, and fatty liver disease. In clinical research , Ginger has been found to effectively treat several conditions associated with flatulence including functional dyspepsia, gastroenteritis, infantile colic, and more ( 1 ). 2. Anise A popular spice in Asian cuisine, Anise is also known for …

TopAlliance Appoints Patricia Keegan, M.D., as Chief Medical Officer Hong Kong Stock Exchange:1877.HK | Globe Newswire | 8/10/2020

… HKEX: 1877; SSE: 688180) today announced the appointment of Dr. Patricia Keegan, as Chief Medical Officer and Senior Vice President. Dr. Keegan brings over three decades of experience as a board-certified medical oncologist, clinical research er, and regulatory authority at FDA. “We are very glad to welcome Patricia on board,” said Ning Li, M.D., Ph.D., Chief Executive Officer of Shanghai Junshi Biosciences. “Dr. Keegan is an accomplished clinician and regulator …

Brittney Moses’ Journey Toward Breaking Mental Health Stigma and Humanizing the Study of Psychology | 8/10/2020

… mental health challenges that they are going through. Brittney is pursuing her journey toward a clinical psychology degree at the University of California, Los Angeles (UCLA). She also assists with research at CAPPS, a clinical research center at the Semel Institute for Neuroscience and Behavior at UCLA. Recently, she has been certified as a facilitator of Recovery Support Groups in her city with the National Alliance of Mental Illness (NAMI …

Brittney Moses’ Journey Toward Breaking Mental Health Stigma and Humanizing the Study of Psychology | 8/10/2020

… mental health challenges that they are going through. Brittney is pursuing her journey toward a clinical psychology degree at the University of California, Los Angeles (UCLA). She also assists with research at CAPPS, a clinical research center at the Semel Institute for Neuroscience and Behavior at UCLA. Recently, she has been certified as a facilitator of Recovery Support Groups in her city with the National Alliance of Mental Illness (NAMI …

New Step by Step Map For gsbm | 8/10/2020

New Step by Step Map For gsbm New Step by Step Map For gsbm Category: Blog Cash are made by countrywide mints and they are recognized by sovereign governments all world wide.gsbm bullion items are manufactured to offer buyers a handy signifies of creating investments in treasured metals. Down below We’re going to Have a look at a number of the a variety of forms of gsbm bullion available today …

Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020 | PRWeb | 8/10/2020

… associated with SARS-CoV-2 infections. The awards program’s applications were reviewed by an exclusive panel of executives from major biotech and pharma companies including Astellas, Accenture, AstraZeneca, Angiocrine Bioscience, Biotech Research Group, NIHR Clinical Research Network, Medidata Solutions and PPD. All applications were evaluated based on the following criteria: effectiveness, technical innovation, competitive advantage, financial impact, and true innovation. Winners will be announced in the 2020 Innovation Report set …

Don’t want to launch Covid vaccine under pressure, says Bharat Biotech CMD | 8/10/2020

… with members of the Chennai International Centre on ‘Covid-19 Endgame Scenarios’ on Saturday. ALSO READ: World Coronavirus Dispatch: Top-5 oil firms cut value of assets by $50 bn “We want to do clinical research of the highest standards. We have been monitored by international agencies and communities. It’s a matter of prestige for the country and for us. We won’t be shortsighted on research and will produce the …

The Definitive Guide to how to make backlinks | 8/10/2020

The Definitive Guide to how to make backlinks The Definitive Guide to how to make backlinks Category: Blog I truly employed to work as being a clinical research er, so possibly that’s the place the scientific impact comes into playSuperior testimonials from you Brian! Thanks for giving this sort of resourceful and astounding Strategies. It’s very beneficial and I need to say that you really have superior stage concerning giving suggestions …

Genome reconstruction of white spot syndrome virus (WSSV) from archival Davidson’s-fixed paraffin embedded shrimp (Penaeus vannamei) tissue | 8/10/2020

… for prospective and retrospective studies, evolutionary studies and opens avenues for pathogen discovery. Download PDF Introduction Formalin-fixed paraffin-embedded (FFPE) archived tissues in human and animal pathology laboratories are an invaluable resource for clinical research , genetic studies and pathogen discovery 1 , 2 , 3 . In human cancer research, the utilization of preserved material from tissue banks has helped circumvent the need to rely upon frozen tissue and has enabled the …

Terns Pharmaceuticals Appoints Senthil Sundaram as Chief Executive Officer, Mark Vignola, Ph.D., as Chief Financial Officer, and Erin Quirk, M.D., as President | Business Wire | 8/10/2020

… personally contributed to the development of 14 approved drug products to date, including initial marketing applications for five novel fixed-dose combinations. Prior to joining Terns in 2019, Dr. Quirk was Vice President of Clinical Research at Gilead Sciences, where she oversaw clinical development activities for investigational HIV treatments, as well as the development strategy and post-marketing studies for the company’s HIV portfolio. Prior to joining Gilead, Dr. Quirk …

Canopy Growth Reports First Quarter Fiscal 2021 Financial Results | PR Newswire | 8/10/2020

… leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research , and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded …

Ocugen Receives Fourth FDA Orphan Drug Designation for the Same Product, OCU400 (AAV-NR2E3) Gene Therapy, for the Treatment of Another Key Inherited Retinal Disease (IRD), PDE6B Gene Mutation-Associated Retinal Diseases Nasdaq:OCGN | Globe Newswire | 8/10/2020

… 200,000 patients in the U.S. Orphan designation qualifies the sponsor of the drug for various development incentives of the Orphan Drug Act, including a seven-year period of U.S. marketing exclusivity, tax credits for clinical research costs, clinical research trial design assistance, the ability to apply for annual grant funding and waiver of Prescription Drug User Fee Act filing fees. About OCU400 OCU400 (AAV-hNR2E3) is a novel gene therapy …

Immunofluorescence Assays Market overview 2019-2025 | 8/10/2020

On the basis of Application , the Global Immunofluorescence Assays market is segmented into: Clinical Research Regional Analysis For Immunofluorescence Assays Market: United States European Union Rest of World (Japan, Korea, India and Southeast Asia) Immunofluorescence Assays Influence of the Immunofluorescence Assays Market Report: -Comprehensive assessment of all opportunities and risk in the Immunofluorescence Assays market. -Immunofluorescence Assays market recent innovations and major events. -Detailed study of business strategies for growth …

Humanigen Expands Phase III Study of Lenzilumab in COVID-19 to Brazil | Business Wire | 8/10/2020

… with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with …

VP of genetics company pleads guilty to paying physicians sham clinical research fees | 8/10/2020

… violation of Medicare’s prohibition against kickbacks, and Proove received approximately $21 million in unlawful payments. Proove concealed the true nature of the kickbacks by falsely characterizing the payments as compensation for participating in a clinical research program sponsored by Proove. In furtherance of the scheme, Proove placed its own employees in doctors’ offices. The Proove employees collected a cheek swab and completed most of the paperwork associated with the “clinical …

WHO praises Boris Johnson for ‘strong and precise’ northern England lockdown | 8/10/2020

… safely enter Shoe Lane Library during the Coronavirus pandemic in the City of London, the capital’s financial district, on 6th August 2020, in London, England. (Photo by Richard Baker / In Pictures via Getty Images) Clinical Research Nurse Aneta Gupta takes bloods from volunteer Yash during the Imperial College vaccine trial at a clinic in London, Wednesday, Aug. 5, 2020. Scientists at Imperial College London are immunizing hundreds of people with …

FDA Clears Appili Therapeutics to Expand its Phase 2 Clinical Trial of Favipiravir for the Potential Prevention of COVID-19 at U.S. Long-Term Care Facilities | Business Wire | 8/10/2020

… assumptions, including with respect to: securing all requisite required approvals and funding for the clinical trial in Canada and the U.S.; finalizing a mutually acceptable clinical trial agreement and related agreements with the applicable clinical research organizations relating to this clinical trial; patient enrolment; and other expectations and assumptions concerning the proposed clinical trial in Canada and the U.S. (including with respect to potential outcomes and benefits). Although the Company …

Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board Furthering the Fight Against Covid-19 Internationally | 8/10/2020

… the Scientific Advisory Board. Dr. Nanhay, a Brazilian physician, has over 25 years of experience in health and biological sciences Dr. Nanhay’s experiences include general medicine practice, emergency medicine, health management, and coordination of clinical research . Dr. Nanhay also had worked for medical and educational institutions including the World Health Organization (WHO), UERJ – Rio de Janeiro, State Secretary of Education and Health Secretariat of São João de Meriti City, and …

90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements | Benzinga | 8/10/2020

BILLERICA, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) – Conformis, Inc. (NASDAQ: CFMS ) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of Bone and Joint Surgery Reviews were satisfied, or very satisfied, 18–28 months post-surgery. In addition, 88% of patients reported that their knees felt natural either some or all of the time. The clinical study, conducted by renowned U.S …

Covid-19 Drug Research is a Big Trouble | 8/10/2020

… away from academic opportunity, so you have a role, and learn how to come together and work together. “ That opportunity is not just ambition. Really disrespectful (if not directly harmful) patients. “When we do clinical research , it̵ 7;s not just a researcher who says, ‘Here’s a great idea, let’s do it.’ Research is a high-stakes effort for all of us.Our patients volunteer, in most cases, to be part …

Reata Pharmaceuticals, Inc. Announces Second Quarter 2020 Financial Results and Provides an Update on Business Operations and Clinical Development Programs | 8/10/2020

… information to demonstrate that it will be difficult to conduct an additional, prospective clinical trial in FA because of the very slow progression rate of FA, the limited number of FA patients available for clinical research , the small number of clinical trial investigators who can conduct the mFARS exam, and the impact of the COVID-19 pandemic on the ability to conduct neuroscience clinical trials. Thus, conducting an additional pivotal …

DARPA’s Man in Wuhan | 8/10/2020

… ICERID, itself, fell through, Vector would nonetheless receive a $600,000 grant from Nunn and Turner’s NTI soon thereafter. Callahan would follow shortly in tow, under the auspices of the U.S. State Department program, leading clinical research teams at Vector and several other important Soviet bioweapons labs to aid in their transformation into profitable ventures. Callahan was also given access to the infamous Institute of Highly Pure Biopreparations (IHPB) where Soviet …

NIH

Extramural Loan Repayment Program for Clinical Researchers (LRP-CR) | National Institutes of Health | 7/16/2020

Extramural Loan Repayment Program for Clinical Researchers (LRP-CR) Notice Number: NOT-OD-19-116 Rescind - Extramural Loan Repayment Program for Clinical Researchers (LRP-CR) Issued by Office of The Director, National Institutes of Health ( OD ) Purpose This Notice replaces NOT-OD-19-116 and provides program-specific information for Extramural Loan Repayment Program for Clinical Researchers (LRP-CR). The NIH Loan Repayment Programs (LRPs) are a set of programs established by …

American Heart Association

AHA News: As Pandemic Disrupts Research, Scientists Look for New Ways Forward | U.S. News & World Report | 7/14/2020

More (HealthDay) TUESDAY, July 14, 2020 (American Heart Association News) – Amid the coronavirus crisis, closed classrooms are the most visible blow universities have taken to their core mission to acquire and share knowledge. But interruptions … as well as projects that require testing and samples for clinical research have been hurt.” The research delays also may have caused gaps in data, he said, and since recruitment for clinical trials was halted …

Precision Medicine

Diabetes and CKD: The Patient Experience, Clinical Research and the Promise of Precision Medicine, Upcoming Webinar Hosted by Xtalks | PRWeb | 7/14/2020

Diabetes and CKD: The Patient Experience, Clinical Research and the Promise of Precision Medicine, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers will discuss the prevalence and impact of clinical Diabetic Kidney Disease (DKD) and that major gaps exist in adherence to accepted monitoring guidelines for DKD. Attendees will learn to appreciate the voice of patients on their experiences living with T1D including concerns …

Patient Safety

Envision Healthcare Earns Recertification as One of Just 94 Federally Designated Patient Safety Organizations in the Nation | Business Wire | 7/14/2020

NASHVILLE, Tenn.- Envision Healthcare, a leading national medical group, announced today that the Envision Healthcare Center for Quality and Patient Safety has been awarded continued listing as a federally certified Patient Safety Organization (PSO) for … pain through opioid-sparing analgesia. The power and utility of clinical research and scientific intelligence in shaping medical advancement. According to the U.S. Department of Health and Human Services Office of the Inspector General, 97 …

American Academy of Pediatrics

11 science-backed ways your parents’ behaviors shaped who you are today | Business Insider | 7/14/2020

… according to one study in the Journal of Marriage and Family. A 2015 study in the Official Journal of the American Academy of Pediatrics found that people perform better in school if their parents set … the 20th century up until today. Countless studies and extensive clinical research have found links between your parents’ behavior during childhood and how you act as an adult. If your mother was constantly juggling multiple …

American Academy of Dermatology

U.S. Dermatology Partners is pleased to welcome Board Certified Dermatologist Amanda Champlain, MD to their Carrollton office July 7th | PRWeb | 7/7/2020

… of Oklahoma College of Medicine. Subsequently, she completed an internship at the University of Southern California in Los Angeles, a Clinical Research Fellowship in the Department of Dermatology at Northwestern University, and dermatology residency training … dermatology and aesthetic meetings. She is a member of the American Academy of Dermatology (AAD), the American Society for Dermatologic Surgery (ASDS), and the American Society for Laser Medicine and Surgery (ASLMS). Dr. Champlain and …

American Association for Cancer Research

Allogene Therapeutics Adds Immunotherapy Luminaries, Thomas F. Gajewski, M.D., Ph.D., and Stephan Grupp, M.D., Ph.D., to its Scientific Advisory Board | Globe Newswire | 7/7/2020

… Institutes of Health (NIH), has served on the program committees for the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR), and is a grant reviewer for the Melanoma Research … at the Children’s Hospital of Philadelphia. His primary area of clinical research is the use of CAR T and other engineered cell therapies in pediatric cancers and other disorders such as sickle cell disease. He …

National Institute of Allergy and Infectious Diseases

Staff Clinician | National Institutes of Health | 7/7/2020

Staff Clinician Job Announcement Description The National Institute of Allergy and Infectious Diseases (NIAID), Division of Intramural Research (DIR), Laboratory of Allergic Diseases (LAD) is offering a position as a staff clinician in clinical and … will aid in the development, implementation, performance, and management of clinical research protocols studying allergic diseases including food allergy and atopic dermatitis in adults and children. The clinician will provide mentorship to clinical staff, including …

Biopharma

CIRION BioPharma Research Inc. Expands its Bioanalytical Services and Offers SARS-CoV-2 and COVID-19 Antibodies Testing Services | PR Newswire | 7/7/2020

LAVAL, QC , July 7, 2020 /PRNewswire/ - CIRION BioPharma Research Inc., a leading provider of large molecule bioanalytical testing and global central laboratory services, announced today that the company is now offering new testing services for … CIRION increases its capacity to support its pharmaceutical clients for clinical research projects including those related to COVID-19. These new testing services are also offered to the support of patients from public and private …

Dermatology

U.S. Dermatology Partners is pleased to welcome Board Certified Dermatologist Amanda Champlain, MD to their Carrollton office July 7th | PRWeb | 7/7/2020

U.S. Dermatology Partners is pleased to welcome Board Certified Dermatologist Amanda Champlain, MD to their Carrollton office July 7th Share Article Board Certified Dermatologist and Fellowship-Trained Laser and Cosmetic Dermatologic Surgeon Amanda Champlain, MD … at the University of Southern California in Los Angeles, a Clinical Research Fellowship in the Department of Dermatology at Northwestern University, and dermatology residency training at Loyola University in Chicago. She was then selected for …

Digital Health

Repurpose.AI and LEO Pharma partner to accelerate drug discovery - Business Insider | 7/6/2020

This story was delivered to Insider Intelligence Digital Health Briefing subscribers earlier this morning. Insider Intelligence publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can … less efficient over time. But AI platforms can comb through clinical research data faster to make novel and more effective predictions than traditional methods. This makes AI especially appealing for pharma firms, considering it takes …

Healthtech

Bio-IT World Announces 2020 Innovative Practices Award Winners | PRWeb | 7/6/2020

… these well-deserving projects with our community.” A panel of expert judges joined the Bio-IT World editors and Cambridge Healthtech Institute executives in reviewing detailed submissions from pharmaceutical companies, academic centers, government agencies, and … BMS Genomics Discovery Hub”). Center for Innovation and Bioinformatics, Neurological Clinical Research Institute, Massachusetts General Hospital The SigNET Platform enables scientific collaboration, integration, analyses, and distribution of research data across studies and repositories. It generates …

NAFLD

Akero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients | Yahoo News | 6/30/2020

… end-of-treatment biopsies, we observed that 48% achieved at least a one-stage improvement in fibrosis without worsening of NAFLD activity score (NAS) and 28% achieved at least a two-stage improvement in fibrosis … to date,” said Stephen Harrison , M.D., medical director of Pinnacle Clinical Research. “I believe Efruxifermin continues to set itself apart as one of the most promising drug candidates in NASH, with impressive histology results after …

National Cancer Institute

Latest Data on IO Combinations Will Be Announced at the IO Combinations 360° Conference October 1-2, 2020 | PRWeb | 6/30/2020

… IL-2. Dr Omid Hamid, The Angeles Clinic and Research Institute, Dr Alexandra Snyder, Merck Research Labs, Dr James Gulley, National Cancer Institute and Dr Raluca Verona, Janssen are co-chairing. Other distinguished speakers including … ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as …

Real World Evidence

National Evaluation System for health Technology Coordinating Center Announces Launch of NEST 1.0 | Business & Finance | heraldchronicle.com | Business Wire | 6/30/2020

… evidence is needed to inform clinical decision-making and keep patients safe,” said Adrian Hernandez, M.D., MHS, professor of Medicine at Duke School of Medicine, vice dean and executive director of the Duke Clinical Research Institute, and chair of the NESTcc Governing Committee. “NESTcc is at the forefront driving transformative and scientifically sound research, and the ecosystem stands to benefit from the evidence resulting from NESTcc’s growth.” NESTcc enables the …

Patient Retention

Akero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients | PR Newswire | 6/30/2020

… encouraging and among the strongest biopsy results reported in NASH to date,” said Stephen Harrison , M.D., medical director of Pinnacle Clinical Research. “I believe Efruxifermin continues to set itself apart as one of the most … efficacy results; and the potential impact of COVID-19 on patient retention, strategy, future operations and clinical trials. Any forward-looking statements in this statement are based on management’s current expectations of future events and …

NIHR

Relationship of CT densitometry to lung physiological parameters and health status in alpha-1 antitrypsin deficiency: initial report of a centralised database of the NIHR rare diseases translational research collaborative | BMJ | 6/30/2020

NIHR funded project to establish collaborative cohorts of patients with rare diseases focused on academic Biomedical Research Units and Wellcome Clinical Research Facilities. The main purpose of this project was to recruit 200 patients (none of whom were receiving augmentation therapy) with AATD (PiZZ genotype) to a central database over a 1-year period as a basis for ongoing collaborative research. The aim of the collaborative was to recruit and …

Medical Innovation

National Evaluation System for health Technology Coordinating Center Announces Launch of NEST 1.0 | Business & Finance | heraldchronicle.com | Business Wire | 6/30/2020

… evidence is needed to inform clinical decision-making and keep patients safe,” said Adrian Hernandez, M.D., MHS, professor of Medicine at Duke School of Medicine, vice dean and executive director of the Duke Clinical Research Institute, and chair of the NESTcc Governing Committee. “NESTcc is at the forefront driving transformative and scientifically sound research, and the ecosystem stands to benefit from the evidence resulting from NESTcc’s growth.” NESTcc enables the …

Genomics

Global Next-generation Sequencing Market By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025 | PR Newswire | 6/30/2020

… Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing and Other Technologies), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others), By Application (Biomarkers & Cancer, Diagnostics … Agilent Technologies, Inc., Qiagen N.V., Hoffmann-La Roche AG, 10x Genomics, Oxford Nanopore Technologies, Takara Bio and others. Years considered for this report: Historical Years: 2015-2018 …

National Institutes of Health

CytoSorbents to Host Key Opinion Leader Call on the Use of CytoSorb Blood Purification to Remove Antithrombotic Medications in Patients at Risk of Bleeding | PR Newswire | 6/29/2020

… 2020 at 11:00 AM EDT , featuring presentations by key experts: Dr. C. Michael Gibson – Harvard University and Baim Institute for Clinical Research, USA Dr. Robert Storey – University of Sheffield, United Kingdom Prof. Dr. med. Michael … Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM), the U.S. Army, U.S. Special Operations Command (USSOCOM …

AdvaMed

Prestigious annual pediatric medical device competition reveals 10 finalists | PR Newswire | 6/29/2020

… as part of the 8 th Annual Symposium on Pediatric Device Innovation, co-located with the MedTech Conference, powered by AdvaMed. NCC-PDI is one of five consortia in the FDA’s Pediatric Device Consortia Grant … Maxim Integrated Ventures, EdgeOne Medical, Experien Group, Greenlight Guru, Proxima Clinical Research, Westwood & Wilshire, and Ximedica. The organization’s industry partners include AdvaMed, Health+Commerce, MedTech Strategist, and Wilson Sonsini Goodrich & Rosati. For more information about …

Critical Care

CytoSorbents to Host Key Opinion Leader Call on the Use of CytoSorb Blood Purification to Remove Antithrombotic Medications in Patients at Risk of Bleeding | PR Newswire | 6/29/2020

MONMOUTH JUNCTION, N.J. CytoSorbents Corporation (NASDAQ: CTSO ), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces that CytoSorbents … Dr. C. Michael Gibson – Harvard University and Baim Institute for Clinical Research, USA Dr. Robert Storey – University of Sheffield, United Kingdom Prof. Dr. med. Michael Schmoeckel – Asklepios-Klinik St. Georg Hamburg, Germany Millions of patients …

Yale University School of Medicine

Patterns of oral anticoagulation use with cardioversion in clinical practice | BMJ | 6/26/2020

Clinical Research Institute , Durham , North Carolina , USA 3 Main Line Health , Bryn Mawr , PA , United States 4 Division of Cardiology , UCLA , Los Angeles , CA , United States 5 Cardiovascular Medicine , Lankenau Institute for Medical Research , Wynnewood , Pennsylvania , USA 6 Cardiovascular Medicine , College of Physicians and Surgeons-Columbia University , New York , New York , USA 7 Harvard Medical School , Boston , MA , United States 8 Cardiovascular Medicine , Yale University School of Medicine , New Haven …

Cardiology

Patterns of oral anticoagulation use with cardioversion in clinical practice | BMJ | 6/26/2020

Sean D Pokorney 2 , 13 1 Duke University Health System , Durham , North Carolina , USA 2 Duke Clinical Research Institute , Durham , North Carolina , USA 3 Main Line Health , Bryn Mawr , PA , United States 4 Division of Cardiology , UCLA , Los Angeles , CA , United States 5 Cardiovascular Medicine , Lankenau Institute for Medical Research , Wynnewood , Pennsylvania , USA 6 Cardiovascular Medicine , College of Physicians and Surgeons-Columbia University , New York , New York , USA 7 Harvard …

Health Research

Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials | Business Wire | 6/25/2020

… candidates to animal challenge studies. We look forward to continue working closely with our collaborators to initiate Phase I/II human clinical trials this summer.” A $4.2M grant from the Canadian Institutes of Health Research (CIHR), Research Nova Scotia (RNS), and the Institute for Ageing (IA) will be used to further develop the Covigenix vaccine candidates through animal challenge studies and human clinical trials. Entos will partner with the Clinical …

AstraZeneca

AstraZeneca scores speedy FDA review for Farxiga based on ‘innovative’ heart attack trial design - FiercePharma | 7/17/2020

AstraZeneca has already taken impressive Farxiga heart failure outcomes results and parlayed them into a watershed approval. Looking at Farxiga’s future in a competitive heart failure market, the company is betting on innovation—and that … will be run in collaboration with the U.K.’s Uppsala Clinical Research Center and Myocardial Ischaemia National Audit Project. AstraZeneca hopes to begin enrollment in the fourth quarter. The British drugmaker’s novel approach to studying …

Merck

Clinical Trials for Evolving Targeted Therapies Fueling Gains for Brain Tumor Therapeutics Market | PR Newswire | 7/15/2020

… CNS Pharmaceuticals, Inc. (NASDAQ: CNSP ), Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ), VBI Vaccines Inc. (NASDAQ: VBIV ), INmune Bio, Inc. (NASDAQ: INMB ), Merck & Co., Inc. (NYSE: MRK ). A recent MarketWatch report said: “Increasing incidence of Brain Cancer … limited options available,” said Dr. Jonathan Cheng , vice president, oncology clinical research, Merck Research Laboratories. “We look forward to working with the FDA to bring KEYTRUDA to more patients with classical Hodgkin lymphoma after initial …

UnitedHealth Group

UnitedHealth Group Continues Efforts to Combat COVID-19, Reports Second Quarter Performance | Business Wire | 7/15/2020

MINNETONKA, Minn.–(BUSINESS WIRE)–Jul 15, 2020– During the second quarter of 2020, UnitedHealth Group (NYSE: UNH) expanded its COVID-19 response efforts, proactively supporting patients, customers, care providers and communities, including investing in outreach … resources to underserved communities. The Company is also leading innovative clinical research to study the elevated risks and treatment options for COVID-19 associated with health conditions that disproportionately impact minority populations. A summary of …

UnitedHealth

UnitedHealth Group Continues Efforts to Combat COVID-19, Reports Second Quarter Performance | Business Wire | 7/15/2020

MINNETONKA, Minn.–(BUSINESS WIRE)–Jul 15, 2020– During the second quarter of 2020, UnitedHealth Group (NYSE: UNH) expanded its COVID-19 response efforts, proactively supporting patients, customers, care providers and communities, including investing in outreach … resources to underserved communities. The Company is also leading innovative clinical research to study the elevated risks and treatment options for COVID-19 associated with health conditions that disproportionately impact minority populations. A summary of …

Merck & Co

Clinical Trials for Evolving Targeted Therapies Fueling Gains for Brain Tumor Therapeutics Market | PR Newswire | 7/15/2020

… CNS Pharmaceuticals, Inc. (NASDAQ: CNSP ), Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ), VBI Vaccines Inc. (NASDAQ: VBIV ), INmune Bio, Inc. (NASDAQ: INMB ), Merck & Co., Inc. (NYSE: MRK ). A recent MarketWatch report said: “Increasing incidence of Brain Cancer … limited options available,” said Dr. Jonathan Cheng , vice president, oncology clinical research, Merck Research Laboratories. “We look forward to working with the FDA to bring KEYTRUDA to more patients with classical Hodgkin lymphoma after initial …

Medrio

Medrio and Avance Clinical Reach 150 Clinical Trials Partnership Milestone | PRWeb | 7/14/2020

Medrio and Avance Clinical Reach 150 Clinical Trials Partnership Milestone Share Article Medrio, Inc and Avance Clinical have surpassed 150 Phase I clinical studies conducted together over an eight-year period. “Medrio has always been … healthier world. Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of …

TriNetX

TriNetX Signs Agreement with FDA Sentinel Program | PR Newswire | 7/14/2020

CAMBRIDGE, Mass. TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced the signing of an agreement with the FDA Sentinel Program. FDA, through its Sentinel Program, is licensing the full TriNetX analytics suite that provides direct access to de-identified real-world data (RWD) in the TriNetX U.S. network for the FDA’s Office of Surveillance and …

HealthDay

AHA News: As Pandemic Disrupts Research, Scientists Look for New Ways Forward | U.S. News & World Report | 7/14/2020

More (HealthDay) TUESDAY, July 14, 2020 (American Heart Association News) – Amid the coronavirus crisis, closed classrooms are the most visible blow universities have taken to their core mission to acquire and share knowledge. But interruptions … as well as projects that require testing and samples for clinical research have been hurt.” The research delays also may have caused gaps in data, he said, and since recruitment for clinical trials was halted …

Regeneron Pharmaceuticals

NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19 - MedCity News | 7/9/2020

… Seattle-based HIV Vaccine Trials Network; the Durham, North Carolina-based HIV Prevention Trials Network; the Atlanta-based Infectious Diseases Clinical Research Consortium; and the Los Angeles-based AIDS Clinical Trials Group. While they will … have nevertheless been incorporated into Operation Warp Speed. These include Regeneron Pharmaceuticals’ late-stage development program for REGN-COV2, a two-antibody cocktail that the company is developing both as a treatment for existing infections …

Regeneron

NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19 - MedCity News | 7/9/2020

… Seattle-based HIV Vaccine Trials Network; the Durham, North Carolina-based HIV Prevention Trials Network; the Atlanta-based Infectious Diseases Clinical Research Consortium; and the Los Angeles-based AIDS Clinical Trials Group. While they will … have nevertheless been incorporated into Operation Warp Speed. These include Regeneron Pharmaceuticals’ late-stage development program for REGN-COV2, a two-antibody cocktail that the company is developing both as a treatment for existing infections …

Bristol-Myers Squibb

Bio-IT World Announces 2020 Innovative Practices Award Winners | PRWeb | 7/6/2020

… Share Article Bio-IT World has announced the winners of the 2020 Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia … BMS Genomics Discovery Hub”). Center for Innovation and Bioinformatics, Neurological Clinical Research Institute, Massachusetts General Hospital The SigNET Platform enables scientific collaboration, integration, analyses, and distribution of research data across studies and repositories. It generates …

Bristol-Myers

Bio-IT World Announces 2020 Innovative Practices Award Winners | PRWeb | 7/6/2020

… Share Article Bio-IT World has announced the winners of the 2020 Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia … BMS Genomics Discovery Hub”). Center for Innovation and Bioinformatics, Neurological Clinical Research Institute, Massachusetts General Hospital The SigNET Platform enables scientific collaboration, integration, analyses, and distribution of research data across studies and repositories. It generates …

Qiagen

Global Next-generation Sequencing Market By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025 | PR Newswire | 6/30/2020

… Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing and Other Technologies), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others), By Application (Biomarkers & Cancer, Diagnostics … Inc., Thermo Fisher Scientific, Inc, BGI Group, Agilent Technologies, Inc., Qiagen N.V., Hoffmann-La Roche AG, 10x Genomics, Oxford Nanopore Technologies, Takara Bio and others. Years considered for this report: Historical Years: 2015-2018 …

Gritstone Oncology

Latest Data on IO Combinations Will Be Announced at the IO Combinations 360° Conference October 1-2, 2020 | PRWeb | 6/30/2020

… Raluca Verona, Janssen are co-chairing. Other distinguished speakers including: Jose Baselga, MD, PhD, AstraZeneca Raphaël F Rousseau, MD, PhD, Gritstone Oncology Alexandra Snyder, MD, Merck Research Labs Kristen Hege, MD, BMS Stephen Baylin, MD … ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as …

Illumina

Global Next-generation Sequencing Market By Product, By Technology, By End User, By Application, By Region, Competition, Forecast & Opportunities, 2025 | PR Newswire | 6/30/2020

… Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing and Other Technologies), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others), By Application (Biomarkers & Cancer, Diagnostics … new and advanced NGS platforms along with rising demand for Illumina’s systems as it uses the SBS technology. Major players operating in the global next-generation sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc …

LifeSci Advisors

CytoSorbents to Host Key Opinion Leader Call on the Use of CytoSorb Blood Purification to Remove Antithrombotic Medications in Patients at Risk of Bleeding | PR Newswire | 6/29/2020

… 2020 at 11:00 AM EDT , featuring presentations by key experts: Dr. C. Michael Gibson – Harvard University and Baim Institute for Clinical Research, USA Dr. Robert Storey – University of Sheffield, United Kingdom Prof. Dr. med. Michael … Relations (732) 398-5394 [email protected] Investor Relations Contact: Jeremy Feffer LifeSci Advisors 917-749-1494 [email protected] U.S. Public Relations Contact: Eric Kim Rubenstein Public Relations 212-805-3052 [email protected] SOURCE CytoSorbents Corporation Related Links http://www.cytosorbents.com …

Merck Research Laboratories

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer | Business Wire | 6/29/2020

… standard of care chemotherapy,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. “Our commitment to pursuing biomarker research continues to help us bring new … and healthy cells. Merck has the industry’s largest immuno-oncology clinical research program. There are currently more than 1,200 trials studying KEYTRUDA across a wide variety of cancers and treatment settings. The KEYTRUDA clinical program …

Fulcrum Therapeutics

Facioscapulohumeral muscular dystrophy community speaks to the FDA | PRWeb | 6/29/2020

… potential exposure to the virus. Nearly 500 people have registered for the virtual event. The meeting is co-sponsored by Fulcrum Therapeutics, Muscular Dystrophy Association, and Optum. Friends of FSH Research is participating as well … that incorporates patient preferences and patient-reported outcomes into FSHD clinical research to ensure that trials are measuring not only statistical success, but also demonstrating meaningful benefit to individuals with FSHD; better understand patient and …

Johnson & Johnson

ArisGlobal Announces Formation of Advisory Board, Bringing Together Industry Veterans to Guide Future Strategy | PR Newswire | 6/29/2020

… as Vice President of Safety Evaluation and Reporting at Pfizer after holding senior leadership roles at Hospira, Sanofi, Cephalon and Johnson & Johnson. Paul Chew , MD : Dr. Chew is currently the President of 1Rx Digipharm Advisory … technology and orchestrated its successful sale to PAREXEL, a global clinical research organization. The formation of the Advisory Board comes during a period of significant growth for ArisGlobal, marked by strong industry adoption of the …

Line Health

Patterns of oral anticoagulation use with cardioversion in clinical practice | BMJ | 6/26/2020

Sean D Pokorney 2 , 13 1 Duke University Health System , Durham , North Carolina , USA 2 Duke Clinical Research Institute , Durham , North Carolina , USA 3 Main Line Health , Bryn Mawr , PA , United States 4 Division of Cardiology , UCLA , Los Angeles , CA , United States 5 Cardiovascular Medicine , Lankenau Institute for Medical Research , Wynnewood , Pennsylvania , USA 6 Cardiovascular Medicine , College of Physicians and Surgeons-Columbia University , New York , New York , USA 7 Harvard …

IBM Watson Health

MATEON IS SELECTED BY IBM WATSON HEALTH FOR THE USE OF IBM CLINICAL DEVELOPMENT SOLUTION AT NO COST FOR PHASE II CLINICAL TRIAL OF OT-101 FOR COVID-19 | Globe Newswire | 6/24/2020

Mateon was approved to use the platform following a review of the program as part of IBM Watson Health’s effort to help support and accelerate promising clinical COVID-19 candidates AGOURA HILLS, Calif., June 24 … II COVID-19 clinical trial. IBM is supporting COVID-19 clinical research through an initiative to help support trial sponsors with promising therapeutic and vaccine candidates. “We are working tirelessly to ensure that OT-101 …

IBM Watson

MATEON IS SELECTED BY IBM WATSON HEALTH FOR THE USE OF IBM CLINICAL DEVELOPMENT SOLUTION AT NO COST FOR PHASE II CLINICAL TRIAL OF OT-101 FOR COVID-19 | Globe Newswire | 6/24/2020

Mateon was approved to use the platform following a review of the program as part of IBM Watson Health’s effort to help support and accelerate promising clinical COVID-19 candidates AGOURA HILLS, Calif., June 24 … II COVID-19 clinical trial. IBM is supporting COVID-19 clinical research through an initiative to help support trial sponsors with promising therapeutic and vaccine candidates. “We are working tirelessly to ensure that OT-101 …

Weill Cornell Medicine

National Evaluation System for health Technology Coordinating Center Announces Six New Governing Committee Members and New Executive Committee Leadership | Business Wire | 6/24/2020

Clinical Research Jennifer Kerr, MS, CCRA, RAC , president, Cook Research Incorporated (MDMA representative) David Maggs, M.D. , vice president, medical affairs, Becton Dickinson Technologies and Innovation Danelle Miller, BS, MA, J.D. , vice president of global regulatory policy and intelligence, Roche Diagnostics (AdvaMed representative) Diane Pickles, BA , program director, One Brave Idea, American Heart Association Art Sedrakyan, M.D., Ph.D. , professor of population health sciences, Weill Cornell Medicine, and director, Institute for Health …

Roche Diagnostics

National Evaluation System for health Technology Coordinating Center Announces Six New Governing Committee Members and New Executive Committee Leadership | Business Wire | 6/24/2020

Clinical Research Jennifer Kerr, MS, CCRA, RAC , president, Cook Research Incorporated (MDMA representative) David Maggs, M.D. , vice president, medical affairs, Becton Dickinson Technologies and Innovation Danelle Miller, BS, MA, J.D. , vice president of global regulatory policy and intelligence, Roche Diagnostics (AdvaMed representative) Diane Pickles, BA , program director, One Brave Idea, American Heart Association Art Sedrakyan, M.D., Ph.D. , professor of population health sciences, Weill Cornell Medicine, and director, Institute for Health …

CVS

American Lung Association Joins Forces with Laura Dern and CVS Health to Raise COVID-19 Research Funds | PR Newswire | 6/23/2020

CHICAGO Award-winning actress Laura Dern is partnering with the American Lung Association and CVS Health to tackle the respiratory disease that has affected us all: COVID-19. From June 21-July 18, 2020 , anyone … COVID-19 research within the current studies of their Airways Clinical Research Centers (ACRC) Network, as well as new coronavirus awards and grants to advance knowledge for preventive research, vaccines, antivirals and future outbreak preparedness …

Leukemia & Lymphoma Society

CBD Unlimited Proud Sponsor for the 2020 Arizona Man of the Year by the Leukemia & Lymphoma Society Other OTC:EDXC | Globe Newswire | 6/30/2020

… today proudly announced the Company sponsored, Dr. Tony Lee, Winner of the 2020 “Arizona Man of the Year” for the Leukemia & Lymphoma Society (LLS). Tony is an outstanding citizen, dedicated to our community and a … science behind these products involves over half a decade of clinical research in the field and lab work in order to protect the accuracy in dosage and delivery of absorption per each serving. In the …

Canopy Growth

The Week In Cannabis: Stocks Tumble As Canopy Dominates The News | Yahoo News | 6/26/2020

This week, the cannabis news world was somewhat dominated by Canopy Growth Corp (NYSE: CGC ). The Smiths Falls, Ontario-based company hosted a virtual investor meeting to discuss the COVID-19 impact and business strategies … naturally derived compounds is also needed for those in the clinical research space. This is what we are focused on developing,” said Susan Chapelle, Co-CEO of Havn Life. ACS Laboratory acquired Botanica Testing Inc …

NCI

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | National Institutes of Health | 6/20/2020

… Institute Nursing Research NINR) National Library Medicine NLM) Fogarty International Center FIC) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS)National Cancer Institute NCI) applications this funding opportunity announcement should fall … index.php ]. Researchers addressing COVID-19 questions, whether population-based for clinical research, strongly encouraged consider COVID-19 specific survey item repositories select existing survey items protocol modules currently being fielded. Additionally, researchers funding through NOSI …

Daiichi Sankyo

Daiichi Sankyo Initiates Clinical Trial with 5th DXd ADC, DS-6157, in Collaboration with Sarah Cannon Research Institute | Business Wire | 5/22/2020

AP Daiichi Sankyo Initiates Clinical Trial with 5th DXd ADC, DS-6157, in Collaboration with Sarah Cannon Research Institute May 22, 2020 42 min ago TOKYO & MUNICH & BASKING RIDGE, N.J. & NASHVILLE, Tenn.–(BUSINESS WIRE)–May … Sarah Cannon Research Institute is one of the world’s leading clinical research organizations conducting community-based clinical trials throughout the United States and United Kingdom. With a focus on advancing therapies for patients, the organization …

Genstar Capital

Advarra Announces Appointment of Gadi Saarony as Chief Executive Officer | PR Newswire | 4/15/2020

… has 25 years of leadership experience. He has served the last 17 years with Parexel International, a leading provider of clinical research, commercialization, technology, and product development consulting services to the Bio/Pharmaceutical industry. In … pursuit of advancing human health.” David Golde , Managing Director of Genstar Capital and Advarra Chairman of the Board, said, “Gadi brings extensive strategic, commercial, and operational leadership in the pharmaceutical services industry and we are …

Morgan Stanley

How Fortune 500 companies are responding to coronavirus pandemic with resources, expertise | Fortune | 4/13/2020

… now essentially shut down the U.S. economy, dozens of companies have donated billions of dollars collectively to combat the crisis. Morgan Stanley has made a $10 million cash commitment to support relief efforts. Twitter and … Converting production lines and/or manufacturing additional critical supplies Conducting clinical research Sharing data and technology Taking measures to keep workers employed, paid, and insured Helping customers get the products and financial assistance they need …

Alkermes

Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety | PR Newswire | 3/31/2020

… Alkermes, and also was VP Neurology at PPD Biotech, a prominent clinical research organization. In these roles, he was responsible for numerous pre-IND to NDA interactions with U.S., European and Japanese regulators. During the course of his career, Dr. de Somer’s clinical leadership has resulted in global regulatory approvals of several drugs, including Exelon® in Alzheimer’s dementia, Comtan® and Stalevo® in Parkinson’s disease, Differin® in dermatology, Artistada® in schizophrenia …

Wellcome Trust

Response to: ‘Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis by Cutolo et al | BMJ | 3/19/2020

Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust. Disclaimer The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. KR, IS, AF and CDB were supported by the National Institutefor Health Research (NIHR) Birmingham Biomedical Research Centre. Competing interests MRD, PS, KP, AK-V and JLM …

Kreos Capital

Nicox Announces 2019 Financial Results and 2020 Key Milestones | Globe Newswire | 3/6/2020

… The December 31, 2019 cash position does not include the last tranche of loan under the bond financing agreement with Kreos Capital which was drawn down in December 2019 but received on January 2, 2020 … clinical trials. She brings over 19 years of experience in clinical research and development in both the Pharmaceutical Industry and Clinical Research Organizations, with the majority of her professional experience in the therapeutic area of …

Zacks Equity Research

Syneos Health (SYNH) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release | Zacks | 2/13/2020

You follow Tale of the Tape - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide Full Article The market expects Syneos Health (SYNH) to … probability of a positive EPS surprise. Zacks Consensus Estimate This clinical research company is expected to post quarterly earnings of $1.01 per share in its upcoming report, which represents a year-over-year change of …

Ladenburg Thalmann

Itamar™ Medical Announces Closing of Upsized Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs | Globe Newswire | 2/4/2020

… clinical research, invest in information technology and facility infrastructure, and for working capital and general corporate purposes. Piper Sandler acted as sole bookrunner for the offering. Ladenburg Thalmann and A.G.P./Alliance Global Partners acted as co-managers for the offering. A registration statement relating to these securities has been filed and was declared effective by the U.S. Securities and Exchange Commission. The offering is being made only by means of …

McKesson Ventures

Lightship Closes $20M Series B Financing Led by McKesson Ventures and Define Ventures and Appoints David MacMurchy as CEO | Business Wire | 2/3/2020

LOS ANGELES–(BUSINESS WIRE)–Feb 3, 2020– Lightship, the premier provider of enterprise level, direct-to-patient clinical research solutions, today announced a $20 million investment led by McKesson Ventures and Define Ventures with participation from Khosla Ventures, Brook Byers, and Marc Benioff and the appointment of David MacMurchy as CEO and Tom Pike as Executive Chairman. “We launched Lightship over a year ago to transform the existing clinical research …

Zacks Investment Research

Icon (NASDAQ:ICLR) Cut to “Hold” at Zacks Investment Research - WKRB News | 2/1/2020

Zacks Investment Research lowered shares of Icon (NASDAQ:ICLR) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According to Zacks, “ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. “ Get Icon alerts: A number of other equities research analysts have also commented on ICLR. UBS …

Maverick Ventures

JPM: Concerto HealthAI unveils $150M raise, t2 pharma data collaborations | FierceBiotech | 1/16/2020

… characteristics of a patient population. The $150 million series B round was led by Declaration Partners with additional backing from Maverick Ventures, AllianceBernstein PCI and SymphonyAI Group. The proceeds will be slated for Concerto’s innovation … revenue gains. “Concerto HealthAI is positioned to empower next-generation clinical research, accelerate breakthrough therapies, and improve patient outcomes.” RELATED: ASCO—Concerto HealthAI uses real-world data to fill the research gap among patients excluded …

The Carlyle Group

Concerto HealthAI Raises $150 Million in Series B Funding | PRWeb | 1/13/2020

… standard for high-performance real-world evidence (RWE) for precision oncology. The company’s mission is to transform healthcare by revolutionizing clinical research models, accelerating insights benefitting patients, and introducing technology solutions that support the entire … family office of David M. Rubenstein, the Co-Founder of The Carlyle Group. Declaration Partners makes direct private equity and real estate investments, including building platform businesses, providing growth equity capital, seeding early stage private …

NovaQuest

Castor Appoints Dr. Ben Cons as Chairman of the Supervisory Board | PR Newswire | 1/8/2020

… Dr. Cons has 20 years of experience with the NYSE-listed pharmaceutical services company IQVIA and its associated investment fund NovaQuest. Currently, Dr. Cons is a Special Partner at the private equity fund Vitruvian, and … unique technology and ambition have the potential to transform how clinical research data is used to inform medical decision making. My colleagues on the Board and I look forward to working with Derk and his …

Piper Jaffray

Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020 | FiercePharma | 1/2/2020

… Pfizer’s Chantix. Aside from GoodRx’s list of meds, Biogen raised prices on several multiple sclerosis drugs in single-digit percentages, Piper Jaffray analyst Christopher Raymond wrote in a note to clients. And AbbVie hiked Humira’s … limit 2020 price increases to 6% for drugs with ongoing clinical research and patient assistance programs. The drugmaker isn’t increasing prices on mature brands this year. Effective January 1, Pfizer raised prices on about 27 …

Frazier Healthcare Partners

40 GI company developments in 2019 | Becker’s ASC Review | 12/23/2019

… Duodenoscope, marking the first time the agency approved a single-use duodenoscope. TKS 1 made an investment in gastrointestinal-focused clinical research company Objective GI. Advanced Medical Solutions Group acquired surgical sealant company Sealantis. Bloomington … intent to acquire competitor Allergan for $63 billion. Takeda and Frazier Healthcare Partners launched Phathom Pharmaceuticals to develop gastrointestinal treatments. A late-stage study for Gilead Science’s drug to treat fibrosis symptoms associated with nonalcoholic …

Vida Ventures

Kinnate Biopharma Closes $74.5M Series B Financing | Business & Finance | heraldchronicle.com | Business Wire | 12/19/2019

… announced today that the company raised $74.5M in an oversubscribed Series B financing. New investors OrbiMed, Nextech Invest Ltd., and Vida Ventures LLC participated in the round along with existing investors Foresite Capital and Eshelman … have precision oncology luminary Dr. Keith Flaherty, M.D., Director of Clinical Research at the Massachusetts General Hospital Cancer Center, join our Board of Directors,” commented Eric Murphy, Ph.D., co-founder and CSO of Kinnate. In …

Kinderhook Industries

Virtual clinical trial platform VirTrial set to acquire SnapMD | MobiHealthNews | 12/16/2019

… week virtual care company VirTrial scooped up fellow telehealth startup SnapMD for an undisclosed sum. Virtrial, a portfolio company of Kinderhook Industries LLC, focuses on providing telemedicine services to the clinical trial industry. Meanwhile SnapMD … team and drive the evolution of telemedicine platforms in the clinical research industry,” David Skibinski, CEO of SnapMD, said in a statement. “This transaction will enable SnapMD to further its commitment to improve access to …

Goldman Sachs

Cannabis company Canopy Growth taps Goldman Sachs’ Hong as IR VP | PE Hub | 11/26/2019

Cannabis company Canopy Growth taps Goldman Sachs’ Hong as IR VP November 26, 2019 By Iris Dorbian Canadian cannabis company Canopy Growth has named Judy Hong as vice president of investor relations. Her appointment becomes … Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics …

Maxim Group

Bridge Bank provides $5 mln loan to Caliber I.D. | PE Hub | 11/26/2019

… million in equity financing in a private placement with existing shareholders. “The Caliber team was pleased to work with the Maxim Group to find a partner like Bridge Bank. The proceeds from these financings will … and ex-vivo confocal microscopy equipment for the medical device, clinical research and life science industries. Headquartered in Andover, Massachusetts, Caliber I.D. has more than 20 years of experience specializing in confocal microscopy. Caliber I.D …

Bridge Bank

Bridge Bank provides $5 mln loan to Caliber I.D. | PE Hub | 11/26/2019

Bridge Bank provides $5 mln loan to Caliber I.D. November 26, 2019 By Iris Dorbian Caliber Imaging & Diagnostics Inc , a provider of confocal microscopy for non-invasive cellular-level imaging of the skin, has secured … and ex-vivo confocal microscopy equipment for the medical device, clinical research and life science industries. Headquartered in Andover, Massachusetts, Caliber I.D. has more than 20 years of experience specializing in confocal microscopy. Caliber I.D …

First Analysis

AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting | PR Newswire | 11/21/2019

AbbVie to Present Latest Clinical Research in the Treatment of Leukemias, Lymphomas and Other Blood Cancers at 2019 ASH Annual Meeting - AbbVie will present more than 40 abstracts featuring data from approved and investigational medicines … 7:00 a.m. – 8:30 a.m. ET Oral Presentation: 8:15 a.m. ET First Analysis from a Phase 1/2 Study of Venetoclaxin Combination with Daratumumab and Dexamethasone, +/- Bortezomib, in Patients with Relapsed/Refractory Multiple Myeloma Oral Session: 6:15 …

Arsenal Capital Partners

Leonard Green & Partners Leads Recapitalization of WCG in Partnership with Arsenal Capital Partners | PR Newswire | 11/14/2019

Leonard Green & Partners Leads Recapitalization of WCG in Partnership with Arsenal Capital Partners Investments Will Further Extend WCG’s Growth Journey News provided by Nov 14, 2019, 07:00 ET Share this article NEW YORK , Nov. 14 … of solutions that measurably improve the quality and efficiency of clinical research. Financial terms of the transaction were not disclosed. WCG is the world’s leading provider of clinical trial optimization solutions. The company enables biopharmaceutical …

Beth Israel Deaconess Medical Center

Beth Israel Deaconess develops tool to help users find the right mental health app | Becker’s Hospital Review | 7/15/2020

Researchers at Boston-based Beth Israel Deaconess Medical Center have developed a tool to help users sort through almost 200 different mental health apps to find one that best meets their needs and preferences. The tool allows users to sort through nearly 200 mental health apps. They can filter the apps based on qualities they deem important, such as price, clinical research to support efficacy, privacy settings, and services and …

Kaiser Permanente

Experimental COVID-19 vaccine safe, generates immune response | National Institutes of Health | 7/15/2020

… virus uses to bind to and enter human cells. The trial was led by Lisa A. Jackson, M.D., MPH, of Kaiser Permanente Washington Health Research Institute in Seattle, where the first participant received the candidate … Kaiser Permanente Washington), UM1AI148576 (Emory University) and UM1AI148684 (Infectious Diseases Clinical Research Consortium). Funding for the manufacture of mRNA-1273 Phase 1 material was provided by the Coalition for Epidemic Preparedness Innovations (CEPI). Article LA …

Beth Israel Deaconess Medical Center, Boston MA

Beth Israel Deaconess develops tool to help users find the right mental health app | Becker’s Hospital Review | 7/15/2020

Researchers at Boston-based Beth Israel Deaconess Medical Center have developed a tool to help users sort through almost 200 different mental health apps to find one that best meets their needs and preferences. The tool allows users to sort through nearly 200 mental health apps. They can filter the apps based on qualities they deem important, such as price, clinical research to support efficacy, privacy settings, and services and …

University Medical Center

16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent | Becker’s Hospital Review | 7/15/2020

University Medical Center (Columbus): Seeks a clinical applications analyst 3. Erlanger Health System (Chattanooga, Tenn.): Seeks a clinical research data analyst 4. Akron (Ohio) Children’s Hospital: Seeks a clinical report analyst Meditech 1. Holy Family Hospital (Methuen, Mass.): Seeks a medical informatics manager 2. Hudson Regional Hospital (Secaucus, N.J.): Seeks an IT financial analyst 3. Grand View Health (Sellersville, Pa.): Seeks a clinical analyst 4. Claxton-Hepburn Medical Center (Ogdensburg …

Regional Hospital

16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent | Becker’s Hospital Review | 7/15/2020

clinical research data analyst 4. Akron (Ohio) Children’s Hospital: Seeks a clinical report analyst Meditech 1. Holy Family Hospital (Methuen, Mass.): Seeks a medical informatics manager 2. Hudson Regional Hospital (Secaucus, N.J.): Seeks an IT financial analyst 3. Grand View Health (Sellersville, Pa.): Seeks a clinical analyst 4. Claxton-Hepburn Medical Center (Ogdensburg, N.Y.): Seeks a clinical systems analyst More articles on EHRs …

Harvard Medical School

TriNetX Signs Agreement with FDA Sentinel Program | PR Newswire | 7/14/2020

CAMBRIDGE, Mass. TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced the signing of an agreement with the FDA Sentinel Program … Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School . “This new contract provides FDA and the HPHCI team access to TriNetX’s growing network of EMRs that we expect to leverage for …

Geisinger

AppliedVR testing the use of at-home virtual reality therapy for chronic pain | FierceHealthcare | 7/13/2020

… immersive VR programs for palliative care and chronic pain with the VA and is also working on clinical trials with Geisinger and Cleveland Clinic to study VR as a replacement for prescription opioids. Amid the … said. “As we engage in and accelerate more in-depth clinical research, we want them to know that we’re committed to making VR a reimbursable standard of care for pain.” RELATED: Here’s a look at …

Department of Veterans Affairs

AppliedVR testing the use of at-home virtual reality therapy for chronic pain | FierceHealthcare | 7/13/2020

… therapy to help ease patients’ acute pain after surgery or during hospitalization. The company also has teamed up with the Department of Veterans Affairs (VA) to target and ease chronic pain in the comfort of … said. “As we engage in and accelerate more in-depth clinical research, we want them to know that we’re committed to making VR a reimbursable standard of care for pain.” RELATED: Here’s a look at …

Mount Sinai Hospital

Dermatologists Say These Face Sunscreens Work Wonders on Signs of Aging | MSN | 7/8/2020

… clinical research in dermatology at Mount Sinai Hospital in New York City. The label on your face sunscreen needs to say “broad spectrum” to guard against both UVA (aging) and UVB (burning) rays, says Arisa Ortiz, M.D. , assistant clinical professor in the department of dermatology at University of California, San Diego. You really have to pay attention to the wording on the bottle because “many sunscreens only protect against UVB …

Memorial Sloan Kettering Cancer Center

ONCOLOGY® Welcomes Six Tumor Chairs to Editorial Advisory Board | Business Wire | 7/8/2020

Clinical Research Office; vice chair, section chief, medical oncology, department of internal medicine; leader, Gastrointestinal Cancer Program; Mayo Clinic. Genitourinary cancer tumor chair: Robert A. Figlin, M.D. , Steven Spielberg family chair, hematology/oncology director, professor of medicine, Cedars Sinai Medical Center. Head and neck tumor chair: Eric J. Sherman, M.D. , medical oncologist, Memorial Sloan Kettering Cancer Center. Hematological malignancies tumor chair: C. Ola Landgren, M.D., Ph.D. , myeloma service chief, Memorial …

Beth Israel Medical Center, New York NY

MEDICAL MARIJUANA: A CLINICAL HANDBOOK Provides Readers the Most Up-to-Date Insights on the Science of Cannabis and Its Medicinal Use | PR Newswire | 7/7/2020

… M.D., M.H.S. is an addiction psychiatrist and Director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center and Associate Professor of Psychiatry at Harvard Medical School . Dr. Hill has conducted clinical research and written on a wide variety of topics including medical cannabis, cannabidiol (CBD), and addiction to alcohol, cannabis, and opioids. As a leading cannabis expert, he has spoken nationally and appeared often on radio and …

Mount Sinai Health System

Mount Sinai Health System and Richmond University Medical Center Announce Expanded Clinical and Academic Affiliation | PRWeb | 7/6/2020

Mount Sinai Health System and Richmond University Medical Center Announce Expanded Clinical and Academic Affiliation Share Article Affiliation will include newly formed comprehensive cancer program, co-branded emergency department, and integrated internal medicine and specialty … the Icahn School of Medicine and Mount Sinai students Offer clinical research opportunities Provide tertiary and quaternary services (including ambulatory specialties) when clinically necessary and appropriate “We look forward to working with our colleagues at …

Methodist Hospital, Houston TX

U.S. Dermatology Partners, is pleased to welcome Kyle Kaltwasser, MD to their Baytown and Clear Lake offices | PRWeb | 7/6/2020

… elected into the Alpha Omega Alpha and Gold Humanism honor societies. Dr. Kaltwasser began his medical internship at the Houston Methodist Hospital located in the Texas Medical Center. He went on to complete his dermatology … team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com . Share article on social media or email: View article via …

Richmond University Medical Center

Mount Sinai Health System and Richmond University Medical Center Announce Expanded Clinical and Academic Affiliation | PRWeb | 7/6/2020

Mount Sinai Health System and Richmond University Medical Center Announce Expanded Clinical and Academic Affiliation Share Article Affiliation will include newly formed comprehensive cancer program, co-branded emergency department, and integrated internal medicine and specialty … the Icahn School of Medicine and Mount Sinai students Offer clinical research opportunities Provide tertiary and quaternary services (including ambulatory specialties) when clinically necessary and appropriate “We look forward to working with our colleagues at …

Boston University School of Medicine

Patterns of oral anticoagulation use with cardioversion in clinical practice | BMJ | 6/26/2020

Sean D Pokorney 2 , 13 1 Duke University Health System , Durham , North Carolina , USA 2 Duke Clinical Research Institute , Durham , North Carolina , USA 3 Main Line Health , Bryn Mawr , PA , United States 4 Division of … Stanford Hospital and Clinics , Stanford , California , USA 11 Cardiovascular Medicine , Boston University School of Medicine , Boston , Massachusetts , USA 12 Penn State Hershey Heart and Vascular Institute , Hershey , Pennsylvania , USA 13 Duke University School of Medicine …

Main Line Health

Patterns of oral anticoagulation use with cardioversion in clinical practice | BMJ | 6/26/2020

Sean D Pokorney 2 , 13 1 Duke University Health System , Durham , North Carolina , USA 2 Duke Clinical Research Institute , Durham , North Carolina , USA 3 Main Line Health , Bryn Mawr , PA , United States 4 Division of Cardiology , UCLA , Los Angeles , CA , United States 5 Cardiovascular Medicine , Lankenau Institute for Medical Research , Wynnewood , Pennsylvania , USA 6 Cardiovascular Medicine , College of Physicians and Surgeons-Columbia University , New York , New York , USA 7 Harvard …

Northwestern Medicine

Friends of Prentice Awards Nearly $500,000 to 2020 Grant Recipients | Globe Newswire | 6/18/2020

Six Projects at Northwestern Medicine Prentice Women’s Hospital will Receive Funding from Friends of Prentice to Conduct Leading-Edge Research Benefitting the Lives of All Women June 18, 2020 11:00 ET Source: Friends of Prentice … B. Mithal, MD, MSCI & Elisheva D. Shanes, MD for their Clinical Research of the impact of COVID-19 on pregnant women, fetuses and infants. The study will look at whether COVID-19 crosses the placenta …

Sylvester Comprehensive Cancer Center

10x Genomics Selects First 45 Members for Visium Clinical Translational Research Network | Globe Newswire | 6/17/2020

RIKEN Center for Biosystems Dynamics Research RIKEN Center for Integrative Medical Sciences Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute, University of Miami Miller School of Medicine University of Michigan Rogel Cancer Center “We are excited to be a part of the collaborative Visium Clinical Translational Research Network and look forward to harnessing the power of spatial gene expression,” said Dr. Sophia Shalhout, Cutaneous Oncology Clinical Research Fellow at …

Children’s Hospital Los Angeles

Children’s Hospital Los Angeles Ranked No. 1 Children’s Hospital in the Western U.S., No. 5 Nationally for Second Straight Year | Yahoo News | 6/16/2020

… Paul S. Viviano . “This honor affirms the work of every CHLA team member and our belief that when parents choose Children’s Hospital Los Angeles, they are choosing the best care for kids.” Every year, U.S … clinical experts at the bedside and the basic, translational, and clinical research conducted in The Saban Research Institute of CHLA …

Brigham and Women's Hospital

Cannabics Pharmaceuticals Appoints Dr. Erez Scapa, MD to its Scientific Board of Advisors | PR Newswire | 6/16/2020

… the Technion Institute of Technology in Haifa, Israel , cum laude. He later held a Research Fellowship in Hepatology at the Brigham and Women’s Hospital, Harvard University , Boston, MA , as well as a fellowship in Endoscopic … licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer. For more information, please visit www.cannabics.com . For the latest updates on Cannabics Pharmaceuticals follow the Company on Twitter …

Dana-Farber Cancer Institute, Boston MA

Cancer patients and doctors carry on with clinical trials during Covid-19 | STAT | 6/16/2020

… in mid-March, just as coronavirus case counts were soaring in Massachusetts. Her treatment, part of a clinical trial at Dana-Farber Cancer Institute in Boston, began with a four-week hospital stay, and since … Paul Sabbatini, an oncologist and deputy physician-in-chief for clinical research. “We and most centers have developed processes to rationally deal with the Covid risk as best we can so [clinical trials] can proceed …

Children's Hospital, Erie PA

Children’s Hospital Los Angeles Ranked No. 1 Children’s Hospital in the Western U.S., No. 5 Nationally for Second Straight Year | Business & Finance | heraldchronicle.com | Business Wire | 6/15/2020

LOS ANGELES–(BUSINESS WIRE)–Jun 16, 2020– Children’s Hospital Los Angeles ( CHLA ) ranks again among the nation’s premier destinations for pediatric care, according to the U.S. News & World Report Best Children’s Hospitals annual list released … clinical experts at the bedside and the basic, translational, and clinical research conducted in The Saban Research Institute of CHLA. In the past year, CHLA has had several notable achievements, including: Breakthrough model for kidney …

Atrium Health

Abiomed Appoints New Chief Medical Officer Charles Simonton, M.D. | Business Wire | 6/15/2020

… Atrium Health. He received his medical degree from Harvard Medical School and did his internship, residency and chief residency in the Department of Internal Medicine at the University of California, San Francisco, and his cardiology fellowship at Duke University. Dr. Simonton’s appointment comes as Abiomed accelerates its clinical research, including multiple FDA randomized control trials (RCTs) such as the STEMI-DTU RCT, the PROTECT IV RCT, and the RECOVER IV …

Baptist Health

Beyond Air Announces First Patient Enrolled in its U.S. Study of Nitric Oxide Therapy Using the LungFit™ System in COVID-19 Patients | Globe Newswire | 6/15/2020

Baptist Health Center for Clinical Research in Little Rock, Arkansas. “The Beyond Air team continues to execute with this most recent accomplishment. The global need to discover a safe and effective treatment for this virus is painfully apparent. We look forward to keeping everyone abreast of the study’s progress over the coming weeks,” said Steve Lisi, Chairman and Chief Executive Officer of Beyond Air. “We believe our LungFit™ system is …

Mount Sinai Hospital, New York NY

Dermatologists Say Ceramides Are the Key to Firmer Skin | Yahoo News | 6/12/2020

… clinical research in dermatology at Mount Sinai Hospital in New York City. Like grout keeps tiles in place and structured, ceramides “help form a waterproof seal on the surface of the skin, preventing loss of hydration, maintaining a healthy skin barrier, and preventing environmental irritation.” What’s the deal with ceramide depletion? OK, so your skin naturally produces ceramides — why would you also need a skincare product that contains the ingredient …

Health Net

Mount Sinai Health System and Richmond University Medical Center Announce Expanded Clinical and Academic Affiliation | PRWeb | 7/6/2020

… clinical research opportunities Provide tertiary and quaternary services (including ambulatory specialties) when clinically necessary and appropriate “We look forward to working with our colleagues at RUMC to expand and advance care for residents of Staten Island,” said Arthur Klein, MD, President of the Mount Sinai Health Network. “Our commitment to the community and shared mission to provide the care that this community deserves is our main goal. For any health …

Mount Sinai rekindles partnership with RUMC through academic, clinical affiliation | Crain’s New York Business | 6/29/2020

… a way to increase Mount Sinai’s outpatient footprint on Staten Island, said Dr. Arthur Klein, president of the Mount Sinai Health Network. “Over the last couple of years, management at RUMC has made real progress … recruitment and provide opportunities for the hospital to participate in clinical research. It is exploring whether the Icahn School of Medicine at Mount Sinai would sponsor residency programs at the hospital. Doctors at RUMC will …

Harvard Pilgrim Health Care

TriNetX & Harvard Pilgrim Health Care Institute Partner on FDA Sentinel System to Monitor COVID-19 Drug Usage | PR Newswire | 5/21/2020

CAMBRIDGE, Mass. TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) is working with the FDA Sentinel Operations Center at the Harvard Pilgrim Health Care Institute (HPHCI) to monitor priority drugs used for the care of hospitalized COVID-19 patients. HPHCI is leveraging TriNetX’s de-identified COVID-19 clinical data set to support studies aimed to sequentially monitor …

Understanding childhood obesity in the US: the NIH environmental influences on child health outcomes (ECHO) program | Nature | 10/24/2019

… Diane J. Catellier Division of Chronic Disease Research Across the Lifecourse (CoRAL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA Emily Oken Department of Epidemiology, Johns Hopkins … Andrea E. Cassidy-Bushrow Welch Center for Epidemiology, Prevention and Clinical Research, Johns Hopkins University Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Noel T. Mueller Department of Public Health …

Cigna

50 things to know about Amazon, Google and Apple in healthcare | Becker’s Hospital Review | 2/11/2020

… Providence in Renton, Wash.; Boston Children’s Hospital; and Atrium Health in Charlotte, N.C., as well as Livongo, Express Scripts and Cigna as part of the exclusive program. 7. Amazon Prime users began to receive email … in its portfolio. The company’s investments have focused on genomics, clinical research, insurance and benefits. 21. Google’s revenues were up in 2018, jumping 23 percent to $136.2 billion. 22. In February, Google Cloud partnered with …

Calculating the Costs of Clinical Trials | 12/1/2019

… have to worry about costs could make a big difference.” At the NIH Clinical Center, a hospital devoted entirely to clinical research, the costs of participating in a clinical trial are completely covered, Dr. Millum … will apply to routine care costs in clinical trials.” 6 Cigna’s clinical trial fact sheet notes that routine patient services, such as transplant-related services or select outpatient services, are managed the same way whether …

Humana

55 things to know about Epic, Cerner, Meditech, Allscripts and Athenahealth | Becker’s Hospital Review | 2/4/2020

… estimated its multiyear technology upgrade, which included the EHR implementation, encompassed $1.5 billion worth of investments. 4. Epic partnered with Humana in June to advance interoperability and transparency between them. Humana integrated its real-time … the year, Allscripts partnered with Microsoft to design a new clinical research model that would leverage EHR and other technologies clinicians use when providing treatment. The collaboration aims to speed up the development of new …

MCRA Strengthens its Reimbursement, Health Economics, and Market Access Division with the Hiring of Tess Wong, MS | PR Newswire | 1/16/2020

… provided by Jan 16, 2020, 15:06 ET Share this article WASHINGTON , Jan. 16, 2020 /PRNewswire/ – MCRA, LLC, is a leading clinical research organization (CRO) and advisory firm specializing in medical devices and biologics. Its integration … Market Access and Health Policy at ADVI, and managed care (Humana). Throughout her career, Tess has evaluated and interpreted US and global healthcare systems, federal rules, reimbursement policies, technology assessments, and economic analyses through retrospective …

Aetna

BIG TECH IN HEALTHCARE: How Alphabet, Amazon, Apple, and Microsoft are shaking up healthcare — and what it means for the future of the industry (GOOGL, AAPL, AMZN, MSFT) | Business Insider | 1/31/2020

… and health record system to narrow its focus on its cloud offerings for health systems, Apple is knuckling down on clinical research initiatives via its wearables, Alphabet is focusing on its AI expertise to drive … healthcare. The companies mentioned in this report are: AbbVie, Adidas, Aetna, Allscripts, Alphabet, Amazon, Ancestry, Apple, Ascension, Berkshire Hathaway, Blue Cross Blue Shield, Bright Health, Calico, Cerner, Cleveland Clinic, Clover Health, Color, CVS, CVS Caremark …

Everlywell Appoints Dr. Judith Rodin to Board of Directors; Welcomes New Members to its Scientific Advisory Board | PR Newswire | 12/6/2019

… A seasoned leader in healthcare, academia, and technology, Dr. Rodin has served as a board member for several corporations, including Aetna, Citigroup, and Comcast NBCUniversal; and has served as an advisor to President Clinton as … and looks to expand into areas such as testing innovation, clinical research and virtual care. “Everlywell is positioned to bring convenient, affordable testing options to millions of people over the next few years, including many …

Wui-Jin Koh

NCCN Explores Adoption of Biosimilars in Oncology in Collaboration with Pfizer | PR Newswire | 7/15/2020

… for biologics and biosimilars—in keeping with FDA guidance —can increase treatment options while generating cancer care cost savings,” said Wui-Jin Koh , MD, Chief Medical Officer, NCCN . “A recent RAND corporation study found that … the lives of people with cancer and supports preclinical, translational, clinical research and quality improvement projects in oncology. For more information, visit NCCN.org/ORP . About the National Comprehensive Cancer Network The National Comprehensive Cancer Network …

Alex Azar

NIAID creates new COVID-19 drug and vaccine trial network through Trump’s Warp Speed program | FierceBiotech | 7/9/2020

… HIV Vaccine Trials Network, based in Seattle; the HIV Prevention Trials Network, based in Durham, North Carolina; the Infectious Diseases Clinical Research Consortium, based in Atlanta; and the AIDS Clinical Trials Group, based in Los … January 2021,” said Department of Health and Human Services Secretary Alex Azar. “Starting this summer, this new network will leverage existing infrastructure and engage communities to secure the thousands of volunteers needed for late-stage …

Mandel Ngan

NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19 - MedCity News | 7/9/2020

… Seattle-based HIV Vaccine Trials Network; the Durham, North Carolina-based HIV Prevention Trials Network; the Atlanta-based Infectious Diseases Clinical Research Consortium; and the Los Angeles-based AIDS Clinical Trials Group. While they will … that could be ready for use by next year. Photo: Mandel Ngan, AFP, via Getty Images Promoted …

Steven Spielberg

ONCOLOGY® Welcomes Six Tumor Chairs to Editorial Advisory Board | Business Wire | 7/8/2020

Clinical Research Office; vice chair, section chief, medical oncology, department of internal medicine; leader, Gastrointestinal Cancer Program; Mayo Clinic. Genitourinary cancer tumor chair: Robert A. Figlin, M.D. , Steven Spielberg family chair, hematology/oncology director, professor of medicine, Cedars Sinai Medical Center. Head and neck tumor chair: Eric J. Sherman, M.D. , medical oncologist, Memorial Sloan Kettering Cancer Center. Hematological malignancies tumor chair: C. Ola Landgren, M.D., Ph.D. , myeloma service chief, Memorial …

Gary Warren

ivWatch SmartTouch™ Sensor Receives FDA Clearance for Continuous IV Site Monitoring | PR Newswire | 7/7/2020

… caused by IV therapy. Having continuous IV site monitoring available in all hospital departments is critical to our mission,” said Gary Warren , President and CEO of ivWatch. “We recognize that all clinical scenarios vary and … Our innovative monitored IV solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch or Facebook @ivWatchLLC , or visit www.ivWatch.com . SOURCE ivWatch, LLC Related Links www.ivwatch.com …

Stuart Titus

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History | PR Newswire | 7/6/2020

… job growing our sales and operations in Latin America as proven by June’s success,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus . “We are fortunate and thankful to have many loyal customers who continue to … cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies , Inc . and Kannalife, Inc . Medical Marijuana, Inc …

Stephen Harrison

Akero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients | PR Newswire | 6/30/2020

Stephen Harrison , M.D., medical director of Pinnacle Clinical Research. “I believe Efruxifermin continues to set itself apart as one of the most promising drug candidates in NASH, with impressive histology results after just 16 weeks of treatment.” Summary of Week 16 Biopsy Endpoints 1 Measure (Mean) Placebo (N=2) All EFX (N=40) 28mg (N=13) 50mg (N=13) 70mg (N=14) Improvement in at least one stage of fibrosis …

David Dible

Nordic Nanovector to Amend PARADIGME Trial Protocol to Expand Eligible Patient Population | PR Newswire | 6/30/2020

… have been approved, the company will continue to enrol patients under the existing protocol. A close collaboration with the company’s Clinical Research Organisation (CRO) will be prioritised to ensure smooth implementation of the new protocol … 762 Email: [email protected] Media Enquiries Mark Swallow /Frazer Hall/ David Dible (Citigate Dewe Rogerson) Tel: +44 203 926 8535 Email: [email protected] About Nordic Nanovector: Nordic Nanovector is committed to develop and deliver innovative …

C. Michael Gibson

CytoSorbents to Host Key Opinion Leader Call on the Use of CytoSorb Blood Purification to Remove Antithrombotic Medications in Patients at Risk of Bleeding | PR Newswire | 6/29/2020

C. Michael Gibson – Harvard University and Baim Institute for Clinical Research, USA Dr. Robert Storey – University of Sheffield, United Kingdom Prof. Dr. med. Michael Schmoeckel – Asklepios-Klinik St. Georg Hamburg, Germany Millions of patients globally are taking antithrombotic medications, or “blood thinners”, to reduce their risk of stroke and heart attacks. But when they require surgery, they risk life-threatening perioperative bleeding. The call will feature presentations from each of …

Roy Baynes

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer | Business Wire | 6/29/2020

… from KEYNOTE-177 that showed KEYTRUDA monotherapy demonstrated superior progression-free survival compared to standard of care chemotherapy,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck … and healthy cells. Merck has the industry’s largest immuno-oncology clinical research program. There are currently more than 1,200 trials studying KEYTRUDA across a wide variety of cancers and treatment settings. The KEYTRUDA clinical program …

Michael Gibson

CytoSorbents to Host Key Opinion Leader Call on the Use of CytoSorb Blood Purification to Remove Antithrombotic Medications in Patients at Risk of Bleeding | PR Newswire | 6/29/2020

Michael Gibson – Harvard University and Baim Institute for Clinical Research, USA Dr. Robert Storey – University of Sheffield, United Kingdom Prof. Dr. med. Michael Schmoeckel – Asklepios-Klinik St. Georg Hamburg, Germany Millions of patients globally are taking antithrombotic medications, or “blood thinners”, to reduce their risk of stroke and heart attacks. But when they require surgery, they risk life-threatening perioperative bleeding. The call will feature presentations from each of the …

Kolaleh Eskandanian

Prestigious annual pediatric medical device competition reveals 10 finalists | PR Newswire | 6/29/2020

… so we want to encourage the development and design of devices with their unique needs as top of mind,” says Kolaleh Eskandanian , Ph.D., M.B.A, P.M.P , vice president and chief innovation officer at Children’s National Hospital … Maxim Integrated Ventures, EdgeOne Medical, Experien Group, Greenlight Guru, Proxima Clinical Research, Westwood & Wilshire, and Ximedica. The organization’s industry partners include AdvaMed, Health+Commerce, MedTech Strategist, and Wilson Sonsini Goodrich & Rosati. For more information about …

Melinda Gates

Montreal Heart Institute announces COLCORONA trial in patients with COVID-19 passes futility test in interim a… | Globe Newswire | 6/27/2020

… COLCORONA is coordinated by the Montreal Health Innovations Coordinating Center (MHICC) and funded by the Government of Quebec, the Bill & Melinda Gates Foundation, and the National Heart, Lung, and Blood Institute (NHLBI) of the United … Montreal Health Innovations Coordinating Center (MHICC) is a leading academic clinical research organization and an integral part of the Montreal Heart Institute (MHI). The MHICC possesses an established network of collaborators in over 4500 clinical …

John Lewis

Entos Pharmaceuticals Announces Selection of Lead DNA Vaccine Candidates for COVID-19 and a $4.2M Award to Move Forward with Phase I/II Human Trials | Business Wire | 6/25/2020

… efficacy data, we believe our Fusogenix DNA vaccine candidates have the potential to be safe and highly potent vaccines that will provide protection against COVID-19 as well as future coronavirus threats,” said John Lewis, CEO of Entos Pharmaceuticals. “These results reflect the potential of our Fusogenix drug delivery platform which has allowed us to quickly advance lead vaccine candidates to animal challenge studies. We look forward to continue working …

Jonathan Chen

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that is Not Curable by Surgery or Radiation | Business & Finance | heraldchronicle.com | Business Wire | 6/24/2020

… Jonathan Cheng, vice president, clinical research, Merck Research Laboratories. “In KEYNOTE-629, treatment with KEYTRUDA resulted in clinically meaningful and durable responses. Today’s approval is great news for patients with cSCC and further demonstrates our commitment to bringing new treatment options to patients with advanced, difficult-to-treat cancers.” Immune-mediated adverse reactions, which may be severe or fatal, can occur with KEYTRUDA, including pneumonitis, colitis, hepatitis, endocrinopathies, nephritis and …

Chaim Lebovits

BrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for the Treatment of Alzheimer’s Disease | PR Newswire | 6/24/2020

… prodromal to mild Alzheimer’s disease. “Our newly announced Alzheimer’s program is an important strategic expansion of BrainStorm’s clinical pipeline,” said Chaim Lebovits , Chief Executive Officer of BrainStorm. “We see this as an ideal complement to … Stacy Lindborg , Ph.D., Executive Vice President and Head of Global Clinical Research at BrainStorm, said, “We are excited to introduce a novel approach to Alzheimer’s disease that targets both inflammation as well as neurotrophic factors …

Eileen Howard Boone

CVS Health and American Lung Association Join Forces to Combat COVID-19 and Protect Against Future Respiratory Viruses | PR Newswire | 6/22/2020

… and we certainly expect that to be the case with an organization whose work has never been more important,” said Eileen Howard Boone , Senior Vice President, Corporate Social Responsibility & Philanthropy and Chief Sustainability Officer for … respiratory research program within the current studies of the Airways Clinical Research Centers Network as well as to create new research awards and grants to advance knowledge around this new lung disease and its terrible …

Bernie Sanders

Senators Warren, Brown, and Sanders Call for the Government Watchdog to Investigate For-Profit Institutional Review Boards (IRBs) | US Seante | 6/19/2020

… Senators Warren, Brown, and Sanders Call for the Government Watchdog to Investigate For-Profit Institutional Review Boards (IRBs) IRBs review clinical research proposals to ensure that participant rights are protected and the research is conducted … D-Ohio), Ranking Member of the Senate Banking Committee, and Bernie Sanders (I-Vt.), Ranking Member of the Senate Budget Committee, requested that the Government Accountability Office (GAO) study for-profit Institutional Review Boards (IRBs …

Rob Robertson

Mednet and AppBus Partner to Optimize Clinical Trials | PR Newswire | 6/18/2020

… is adding new pressures. Rapid adoption of technologies will be critical to meet these new demands and achieve success,” said Rob Robertson , CEO, Mednet. “With our AppBus partnership, we can now very rapidly integrate and … the tools required to build and manage all types of clinical research, while enabling organizations to adapt to evolving demands and requirements. Pharmaceutical, medical device, biotechnology and Contract Research Organizations (CROs) around the world have …

Francis Crick

ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research | PR Newswire | 6/18/2020

… our common goal of improving patient outcomes. We are delighted BMS chose to leverage our Personalized Cancer Monitoring assays for clinical research aimed at expanding precision oncology into early-stage cancers, when the cancer is … collaboration led by Professor Charles Swanton of UCL and the Francis Crick Institute to detect evidence of disease progression in lung cancer patients from cell-free ctDNA as part of the Cancer Research UK-funded …

Scot Ebbinghaus

FDA Approves Second Biomarker-Based Indication for Merck’s KEYTRUDA® (pembrolizumab), Regardless of Tumor Type | Business Wire | 6/17/2020

… Scot Ebbinghaus, vice president, clinical research, Merck Research Laboratories. “TMB-H, defined as 10 mutations per megabase or more, can help identify patients most likely to benefit from KEYTRUDA. We’re pleased that our collaborative efforts to advance biomarker research have resulted in our ability to provide a new treatment option that addresses a high unmet medical need for these patients with cancer.” “As physicians, we are always looking to find …

Paul Hudson

Sanofi invests to make France its world class center of excellence in vaccine research and production | Globe Newswire | 6/16/2020

… core of its strategy, aiming to make France a world-class center of excellence in vaccine research and production,” said Paul Hudson, Chief Executive Officer at Sanofi. “Sanofi is a major healthcare player in France … risks. The facility will become a world reference for pre-clinical research and pharmaceutical and clinical development. Sanofi expresses its gratitude to the Auvergne-Rhône-Alpes French region for its support in this project. Sanofi …

Alan Condon

EmergeOrtho engages in clinical research for spinal pain | Beckers Spine Review | 6/16/2020

EmergeOrtho engages in clinical research for spinal pain Alan Condon - Raleigh, N.C.-based EmergeOrtho has teamed with Wake Research in Raleigh, N.C., to conduct clinical research on spinal pain. Three things to know: 1. Partnering as Emerging Medical Research, the organization is researching surgical and nonsurgical ways to treat spinal pain. 2. The clinical trials are investigating lumbar surgery, symptomatic cervical disc disease, artificial disc disease and spinal devices. 3 …

Eddie Martucci

In a first, FDA clears video game for kids with ADHD - MedCity News | 6/16/2020

… to be used as a prescription treatment for ADHD. “We’re proud to make history today with FDA’s decision, Akili CEO Eddie Martucci s aid in a news release . “With EndeavorRx, we’re using technology to help … would not have been possible without the dedication of our clinical research partners and hundreds of families who gave their time and energy to participate in our clinical trials.” Aikli said its treatment would be …

Fred Hutchinson

Sensei Biotherapeutics shakes up R&D suite as it nabs new CMO from Merus | FierceBiotech | 6/15/2020

Fred Hutchinson Cancer Research Center where he was scientific director of the immunopathology lab in the clinical research division. The biotech penned a deal with AstraZeneca last summer to wed its experimental cancer drug SNS-301 with the Big Pharma’s checkpoint inhibitor Imfinzi across several solid tumors. In November, it also kick-started its own head and neck cancer trial of the drug. It works as what it described as …